3 results
The aim of this study is to investigate what proportion of HBeAg negative, inactive carriers of the hepatitis B virus with low (< 20,000 IU/mL) load will lose HBsAg when treated with nucleot(s)ide analogue/Peg-IFN combination therapy.
To determine the accuracy and acceptability of a minimal-invasive screening strategy (breath testing (eNose) followed by unsedated transnasal endoscopy (uTNE)) for Barrett*s esophagus (BE) and esophageal adenocarcinoma (EAC).
Primary Objective• To evaluate the efficacy of two dosage regimens of palovarotene compared with placebo in preventing new osteochondromas (OCs) in subjects with multiple osteochondromas (MO) due to exostosin 1 (Ext1) or exostosin 2 (Ext2) mutations…